Whalegun
Home

Acadia Pharmaceuticals ACAD paid Tiber Creek Group $80K for lobbying in Q4 2023 · Health Issues, Medicare

Trade details

Type
Lobbying report
Amount
$80,000
Quarter
Q4 2023
Stock
Acadia Pharmaceuticals ACAD
Client
Acadia Pharmaceuticals
Reported
24/01/13

Up 0.0% from last quarter

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Acadia Pharmaceuticals's other lobbying reports

Acadia Pharmaceuticals ACAD paid Tiber Creek Group $80K for lobbying in Q4 2023 · Health Issues, Medicare | Whalegun